Skip to main content
Clinical Trials/NCT02386202
NCT02386202CompletedNot Applicable

Augmented Renal Clearance in Hemorrhagic Stroke Patients Admitted to the Neurosciences Intensive Care Unit

University of North Carolina, Chapel Hill1 site in 1 country80 target enrollmentStarted: January 2015Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
80
Locations
1
Primary Endpoint
To describe the onset, magnitude, and change over time of ARC in patients with hemorrhagic stroke

Study Overview

Brief Summary

To determine the incidence and predictors of augmented renal clearance (ARC) in patients with hemorrhagic stroke.

Study Design

Study Type
Observational
Time Perspective
Prospective

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Adults ≥ 18 years
  • Patients with hemorrhagic stroke
  • Anticipated length of stay in the neuroscience intensive care unit > 48 hours
  • Informed consent provided by the patient or by the patient's designated medical proxy

Exclusion Criteria

  • Pregnancy
  • Patients with pre-existing renal dysfunction (chronic kidney disease stages 3 - 5)
  • Patients receiving renal replacement therapy
  • Patients with an admission serum creatinine > 1.4 mg/dL
  • Patients with non-aneurysmal subarachnoid hemorrhage
  • Patients with history of nephrectomy or body mass index < 18 kg/m2

Outcomes

Primary Outcomes

To describe the onset, magnitude, and change over time of ARC in patients with hemorrhagic stroke

Time Frame: Over neurosciences intensive care unit stay

Daily 8-hour urine collections will be performed to directly measure creatinine clearance up to ICU discharge

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials